1471 - 1480 of 6456 Results
Title
Year
- Cerebrospinal Fluid Levels of Kininogen‐1 Indicate Early Cognitive Impairment in Parkinson's Disease2020OPENTitle: Cerebrospinal Fluid Levels of Kininogen‐1 Indicate Early Cognitive Impairment in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 2101End Page: 2106Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28192Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28192Citation Count: 29
- Precision Neurology for Parkinson’s Disease: Coupling Miro1‐Based Diagnosis With Drug Discovery2020OPENTitle: Precision Neurology for Parkinson’s Disease: Coupling Miro1‐Based Diagnosis With Drug DiscoveryJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 9Start Page: 1502End Page: 1508Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28194Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28194Citation Count: 15
-
OPENTitle: Implementation of a Novel Bluetooth Technology for Remote Deep Brain Stimulation Programming: The Pre– and Post–COVID‐19 Beijing ExperienceJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 6Start Page: 909End Page: 910Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28098Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28098Citation Count: 40
- A New Approach to the Development of Disease‐Modifying Therapies for PD; Fighting Another Pandemic2020OPENTitle: A New Approach to the Development of Disease‐Modifying Therapies for PD; Fighting Another PandemicJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 59End Page: 63Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28310Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28310Citation Count: 25
- Renal Dysfunction Might Be a Marker of Cardiovascular Dysautonomia in Prodromal Α‐Synucleinopathies2020OPENTitle: Renal Dysfunction Might Be a Marker of Cardiovascular Dysautonomia in Prodromal Α‐SynucleinopathiesJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 2Start Page: 374End Page: 374Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27840Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7122792Citation Count: 2
-
OPENTitle: Diabetes Mellitus Is Associated With an Earlier Age of Onset of Huntington's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 4Start Page: 1033End Page: 1034Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28460Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8842492Citation Count: 8
-
OPENTitle: Resting‐State Functional Connectivity Predicts STN DBS Clinical ResponseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 662End Page: 671Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28376Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7987812Citation Count: 42
-
OPENTitle: Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?Journal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 12Start Page: 2174End Page: 2183Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28220Best OA location URL: https://doi.org/10.1002/mds.28220Citation Count: 39
-
OPENTitle: Phenomenology and Outcomes of In‐Patients With Parkinson's Disease During the Coronavirus Disease 2019 PandemicJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 8Start Page: 1295End Page: 1296Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28205Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28205Citation Count: 24
- Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase–Associated Neurodegeneration2020OPENTitle: Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase–Associated NeurodegenerationJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1342End Page: 1352Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28392Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28392Citation Count: 26